The global medical radiation shielding market is on a trajectory of remarkable growth, with an estimated value of $1.8 billion projected by 2028, marking a Compound Annual Growth Rate (CAGR) of 6.5% from 2023 to 2028. The market's expansion is underpinned by the escalating use of nuclear medicine and radiation therapy for diagnostic and treatment purposes, alongside growing cancer incidences and heightened safety awareness in radiation-prone environments.
A comprehensive research study undertaken by industry experts presents an in-depth analysis of the medical radiation shielding market, encompassing key insights into industry trends, pricing dynamics, patent analysis, conference materials, stakeholder engagement, and market behaviors. This study underscores the pivotal role that medical radiation shielding plays in shaping the healthcare landscape.
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/medical-radiation-shielding-market-124318639.html
ESCO Technologies Inc. (US)
ESCO Technologies Inc. (US) is an industry player in designing and manufacturing products which provide its customers with the ability to identify, measure and contain magnetic, electromagnetic and acoustic energy. The company has three business operations segments i.e. Aerospace & Defense (A&D), Utility Solutions Group (USG) and RF Shielding and Test. The RF Shielding and Test segment’s operations consist of ETS-Lindgren Inc. and related subsidiaries (ETS-Lindgren). It offers customers with a broad range of RF test facilities like RF and magnetically shielded rooms which includes features like shielded doors and windows. For instance, In September 2022, ETS-Lindgren had a partnership with the IMRIS, Deerfield Imaging for opening Hale Family building that will offer diagnostic and treatment capabilities during surgery. Also, In September 2022, ETS-Lindgren will display innovative products and services for MRI imaging and healthcare professionals at several industry-leading trade including the Healthcare Facilities Symposium & Expo, HCF 2022.
Mirion Technologies Inc. (US)
Mirion Technologies Inc. (US) is a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets. Mirion Technologies Inc. has two reportable business segments, namely, Medical and Industrial.
The company offers radiation detection, monitoring, and safety products through the medical segment. Products and solutions of the Medical segment include dosimetry services (environmental radiation monitoring the dose of records services), cancer diagnostics and therapy quality assurance, nuclear medicine, dosimeters (wearable devices that measure exposure to ionizing radiation), contamination and clearance monitors, detection and identification instruments, radiation monitoring systems, electrical penetrations, reactor instrumentation and control equipment and systems.
The company has a wide geographical reach globally, in the Americas, Europe, Africa, the Middle East and Asia Pacific regions. It offers products and services to the private sector and government clients in developed and emerging markets. Further, Mirion is headquartered in Atlanta, Georgia and has operations in the US, Canada, the UK, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, Japan, and South Korea. For Instance, In Janauary 2021, Mirion Technologies acquired Sun Nuclear Corporation, which is present in over 100 countries. This acquisition was meant to strengthen Mirion’s position in the market and In September 2020, Mirion acquired Biodex Medical Systems, a leader in the medical industry that offers nuclear medicine instruments, medical imaging equipment, and rehabilitation systems.
Sources
Related
https://chatterchat.com/read-blog/57424
https://jointcorners.com/read-blog/22979
https://menagerie.media/index.php?link1=read-blog&id=29575
https://blooder.net/read-blog/26087
https://www.zedlike.com/blogs/133511/Global-Medical-Radiation-Shielding-Market-Set-to-Reach-1-8
https://cryptofriender.com/read-blog/20315
https://chandrabindu.net/read-blog/9420
https://facerelation.com/read-blog/19597
https://vherso.com/read-blog/100875
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek